Two Sigma Securities, LLC Novavax Inc Transaction History

Two Sigma Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $75,951 - $108,404	11,387 New	11,387 $84,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $291,618 - $605,181	-8,038 Reduced 43.63%	10,385 $534,000
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $1.16 Million - $2.37 Million	16,600 Added 910.59%	18,423 $1.36 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $245,302 - $397,359	1,823 New	1,823 $261,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.